Prevalence of Detection of Clostridioides difficile Among Asymptomatic Children: A Systematic Review and

Sarah R Tougas1, Nidhi Lodha1, Ben Vandermeer2

  • 1Cumming School of Medicine, Department of Pediatrics, University of Calgary, Calgary, Alberta, Canada.

JAMA Pediatrics
|August 2, 2021
PubMed

Insights

Clostridioides difficile (C difficile) detection rates are highest in infants aged 6-12 months, decreasing with age. These findings offer crucial context for interpreting C difficile test results in children.

Area of Science:

  • Microbiology
  • Epidemiology
  • Pediatrics

Background:

  • Clostridioides difficile detection is common in asymptomatic children, but prevalence data across age groups is limited.
  • Accurate prevalence estimates are needed to interpret diagnostic test results in pediatric populations.

Purpose of the Study:

  • To determine the prevalence of Clostridioides difficile detection in asymptomatic children across the entire age spectrum.
  • To analyze factors influencing C difficile prevalence, including age, geographic region, income status, and testing methodology.

Main Methods:

  • A systematic review and meta-analysis was conducted, searching multiple databases (Cochrane, MEDLINE, Embase, etc.) for studies published between 1990 and 2020.
  • Included studies reported C difficile testing in children under 18 without diarrhea. Data were extracted following PRISMA guidelines and pooled using a random-effects model.

Main Results:

  • Ninety-five studies comprising 19,186 participants were analyzed.
  • C difficile detection rates were highest in infants aged 6-12 months (41%) and decreased to 12% in children aged 5-18 years.
  • Toxigenic C difficile colonization peaked at 14% in 6-12 month olds, decreasing to 6% in older children. Prevalence varied by region but not by testing method, income, or time period.

Conclusions:

  • Clostridioides difficile colonization prevalence in children peaks in infancy and declines with age.
  • These age-specific prevalence data are essential for contextualizing C difficile test results in pediatric patients.
  • Understanding asymptomatic colonization patterns aids in appropriate clinical decision-making and reduces potential misinterpretation of diagnostic findings.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
39
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
57
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
44
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
47